nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HTR2B—cardial valve—dilated cardiomyopathy	0.0589	0.351	CbGeAlD
Amoxapine—Drug fever—Spironolactone—dilated cardiomyopathy	0.0345	0.0805	CcSEcCtD
Amoxapine—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0208	0.0486	CcSEcCtD
Amoxapine—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.0206	0.123	CbGeAlD
Amoxapine—HTR7—pulmonary artery—dilated cardiomyopathy	0.0204	0.122	CbGeAlD
Amoxapine—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.0199	0.118	CbGeAlD
Amoxapine—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0178	0.0415	CcSEcCtD
Amoxapine—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0127	0.0758	CbGeAlD
Amoxapine—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0124	0.0737	CbGeAlD
Amoxapine—Vasculitis—Spironolactone—dilated cardiomyopathy	0.0118	0.0275	CcSEcCtD
Amoxapine—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.0107	0.0249	CcSEcCtD
Amoxapine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0103	0.0241	CcSEcCtD
Amoxapine—DRD4—heart—dilated cardiomyopathy	0.00887	0.0527	CbGeAlD
Amoxapine—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00809	0.0189	CcSEcCtD
Amoxapine—Ataxia—Spironolactone—dilated cardiomyopathy	0.00786	0.0184	CcSEcCtD
Amoxapine—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00723	0.0169	CcSEcCtD
Amoxapine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00715	0.0167	CcSEcCtD
Amoxapine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00665	0.0155	CcSEcCtD
Amoxapine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00644	0.015	CcSEcCtD
Amoxapine—Vasculitis—Furosemide—dilated cardiomyopathy	0.00642	0.015	CcSEcCtD
Amoxapine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00601	0.014	CcSEcCtD
Amoxapine—Mental disability—Furosemide—dilated cardiomyopathy	0.00544	0.0127	CcSEcCtD
Amoxapine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00511	0.0119	CcSEcCtD
Amoxapine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00508	0.0119	CcSEcCtD
Amoxapine—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00482	0.0112	CcSEcCtD
Amoxapine—Purpura—Furosemide—dilated cardiomyopathy	0.00472	0.011	CcSEcCtD
Amoxapine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00451	0.0105	CcSEcCtD
Amoxapine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00432	0.0101	CcSEcCtD
Amoxapine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00414	0.00967	CcSEcCtD
Amoxapine—Asenapine—ADRB1—dilated cardiomyopathy	0.00409	0.457	CrCbGaD
Amoxapine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00402	0.00939	CcSEcCtD
Amoxapine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00389	0.00909	CcSEcCtD
Amoxapine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00385	0.009	CcSEcCtD
Amoxapine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00374	0.00874	CcSEcCtD
Amoxapine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00368	0.00859	CcSEcCtD
Amoxapine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00365	0.00853	CcSEcCtD
Amoxapine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00363	0.00848	CcSEcCtD
Amoxapine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.0036	0.00841	CcSEcCtD
Amoxapine—Drowsiness—Furosemide—dilated cardiomyopathy	0.0035	0.00818	CcSEcCtD
Amoxapine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00348	0.00813	CcSEcCtD
Amoxapine—Asenapine—ADRB2—dilated cardiomyopathy	0.00344	0.385	CrCbGaD
Amoxapine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00338	0.0079	CcSEcCtD
Amoxapine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00338	0.0079	CcSEcCtD
Amoxapine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00327	0.00764	CcSEcCtD
Amoxapine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00326	0.00762	CcSEcCtD
Amoxapine—HTR2B—heart—dilated cardiomyopathy	0.00326	0.0194	CbGeAlD
Amoxapine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00325	0.00758	CcSEcCtD
Amoxapine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00321	0.00749	CcSEcCtD
Amoxapine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00293	0.00685	CcSEcCtD
Amoxapine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00292	0.00682	CcSEcCtD
Amoxapine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00291	0.00679	CcSEcCtD
Amoxapine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00289	0.00675	CcSEcCtD
Amoxapine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00281	0.00656	CcSEcCtD
Amoxapine—HTR7—heart—dilated cardiomyopathy	0.00279	0.0166	CbGeAlD
Amoxapine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00272	0.00634	CcSEcCtD
Amoxapine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00272	0.00634	CcSEcCtD
Amoxapine—Flatulence—Furosemide—dilated cardiomyopathy	0.0027	0.0063	CcSEcCtD
Amoxapine—ADRA1A—heart—dilated cardiomyopathy	0.00269	0.016	CbGeAlD
Amoxapine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00268	0.00627	CcSEcCtD
Amoxapine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00268	0.00626	CcSEcCtD
Amoxapine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00261	0.0061	CcSEcCtD
Amoxapine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00259	0.00605	CcSEcCtD
Amoxapine—Rash—Spironolactone—dilated cardiomyopathy	0.00259	0.00605	CcSEcCtD
Amoxapine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00259	0.00604	CcSEcCtD
Amoxapine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00258	0.00603	CcSEcCtD
Amoxapine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00258	0.00602	CcSEcCtD
Amoxapine—Headache—Spironolactone—dilated cardiomyopathy	0.00257	0.00601	CcSEcCtD
Amoxapine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00256	0.00598	CcSEcCtD
Amoxapine—Agitation—Furosemide—dilated cardiomyopathy	0.00252	0.00588	CcSEcCtD
Amoxapine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00245	0.00573	CcSEcCtD
Amoxapine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00245	0.00572	CcSEcCtD
Amoxapine—Nausea—Spironolactone—dilated cardiomyopathy	0.00244	0.0057	CcSEcCtD
Amoxapine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00236	0.00551	CcSEcCtD
Amoxapine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00235	0.00548	CcSEcCtD
Amoxapine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00228	0.00532	CcSEcCtD
Amoxapine—Confusional state—Furosemide—dilated cardiomyopathy	0.00225	0.00526	CcSEcCtD
Amoxapine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.0022	0.00514	CcSEcCtD
Amoxapine—Shock—Furosemide—dilated cardiomyopathy	0.0022	0.00513	CcSEcCtD
Amoxapine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00219	0.00511	CcSEcCtD
Amoxapine—Anorexia—Furosemide—dilated cardiomyopathy	0.00213	0.00497	CcSEcCtD
Amoxapine—Hypotension—Furosemide—dilated cardiomyopathy	0.00209	0.00488	CcSEcCtD
Amoxapine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00209	0.00487	CcSEcCtD
Amoxapine—ADRA2A—heart—dilated cardiomyopathy	0.00205	0.0122	CbGeAlD
Amoxapine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00202	0.00473	CcSEcCtD
Amoxapine—Tension—Lisinopril—dilated cardiomyopathy	0.00202	0.00471	CcSEcCtD
Amoxapine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00201	0.0047	CcSEcCtD
Amoxapine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00201	0.00469	CcSEcCtD
Amoxapine—Nervousness—Lisinopril—dilated cardiomyopathy	0.002	0.00466	CcSEcCtD
Amoxapine—Somnolence—Furosemide—dilated cardiomyopathy	0.00199	0.00464	CcSEcCtD
Amoxapine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00194	0.00454	CcSEcCtD
Amoxapine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00194	0.00452	CcSEcCtD
Amoxapine—Fatigue—Furosemide—dilated cardiomyopathy	0.00193	0.0045	CcSEcCtD
Amoxapine—Tremor—Lisinopril—dilated cardiomyopathy	0.00192	0.00449	CcSEcCtD
Amoxapine—Constipation—Furosemide—dilated cardiomyopathy	0.00191	0.00446	CcSEcCtD
Amoxapine—Syncope—Lisinopril—dilated cardiomyopathy	0.00184	0.0043	CcSEcCtD
Amoxapine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00184	0.0043	CcSEcCtD
Amoxapine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00184	0.00429	CcSEcCtD
Amoxapine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00183	0.00427	CcSEcCtD
Amoxapine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00182	0.00424	CcSEcCtD
Amoxapine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00181	0.00422	CcSEcCtD
Amoxapine—Urticaria—Furosemide—dilated cardiomyopathy	0.00178	0.00415	CcSEcCtD
Amoxapine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00177	0.00413	CcSEcCtD
Amoxapine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00177	0.00413	CcSEcCtD
Amoxapine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00175	0.0104	CbGeAlD
Amoxapine—HTR2A—heart—dilated cardiomyopathy	0.00174	0.0103	CbGeAlD
Amoxapine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00171	0.00399	CcSEcCtD
Amoxapine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00169	0.00395	CcSEcCtD
Amoxapine—Oedema—Lisinopril—dilated cardiomyopathy	0.00168	0.00392	CcSEcCtD
Amoxapine—Shock—Lisinopril—dilated cardiomyopathy	0.00165	0.00385	CcSEcCtD
Amoxapine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00164	0.00383	CcSEcCtD
Amoxapine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00164	0.00382	CcSEcCtD
Amoxapine—Asthenia—Furosemide—dilated cardiomyopathy	0.0016	0.00374	CcSEcCtD
Amoxapine—Anorexia—Lisinopril—dilated cardiomyopathy	0.0016	0.00373	CcSEcCtD
Amoxapine—Pruritus—Furosemide—dilated cardiomyopathy	0.00158	0.00369	CcSEcCtD
Amoxapine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00157	0.00366	CcSEcCtD
Amoxapine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00153	0.00357	CcSEcCtD
Amoxapine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00152	0.00354	CcSEcCtD
Amoxapine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00151	0.00352	CcSEcCtD
Amoxapine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00149	0.00348	CcSEcCtD
Amoxapine—Dizziness—Furosemide—dilated cardiomyopathy	0.00148	0.00345	CcSEcCtD
Amoxapine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00148	0.00345	CcSEcCtD
Amoxapine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00146	0.0034	CcSEcCtD
Amoxapine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00145	0.00338	CcSEcCtD
Amoxapine—Constipation—Lisinopril—dilated cardiomyopathy	0.00143	0.00335	CcSEcCtD
Amoxapine—Vomiting—Furosemide—dilated cardiomyopathy	0.00142	0.00332	CcSEcCtD
Amoxapine—Loxapine—ADRB1—dilated cardiomyopathy	0.00141	0.158	CrCbGaD
Amoxapine—Rash—Furosemide—dilated cardiomyopathy	0.00141	0.00329	CcSEcCtD
Amoxapine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00141	0.00329	CcSEcCtD
Amoxapine—Headache—Furosemide—dilated cardiomyopathy	0.0014	0.00327	CcSEcCtD
Amoxapine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00138	0.00323	CcSEcCtD
Amoxapine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00137	0.0032	CcSEcCtD
Amoxapine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00133	0.00311	CcSEcCtD
Amoxapine—Nausea—Furosemide—dilated cardiomyopathy	0.00133	0.0031	CcSEcCtD
Amoxapine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00133	0.0031	CcSEcCtD
Amoxapine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00133	0.0031	CcSEcCtD
Amoxapine—Asthenia—Lisinopril—dilated cardiomyopathy	0.0012	0.00281	CcSEcCtD
Amoxapine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00119	0.00277	CcSEcCtD
Amoxapine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00115	0.00268	CcSEcCtD
Amoxapine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00111	0.00259	CcSEcCtD
Amoxapine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00107	0.00249	CcSEcCtD
Amoxapine—Rash—Lisinopril—dilated cardiomyopathy	0.00106	0.00247	CcSEcCtD
Amoxapine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00106	0.00247	CcSEcCtD
Amoxapine—Headache—Lisinopril—dilated cardiomyopathy	0.00105	0.00245	CcSEcCtD
Amoxapine—Nausea—Lisinopril—dilated cardiomyopathy	0.000996	0.00233	CcSEcCtD
Amoxapine—DRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.84e-05	0.000224	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.84e-05	0.000224	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.8e-05	0.000223	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.75e-05	0.000222	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.73e-05	0.000221	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.73e-05	0.000221	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.72e-05	0.000221	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.69e-05	0.00022	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—AGT—dilated cardiomyopathy	8.59e-05	0.000218	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.57e-05	0.000217	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.57e-05	0.000217	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.55e-05	0.000217	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.53e-05	0.000216	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.52e-05	0.000216	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.51e-05	0.000216	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.48e-05	0.000215	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.44e-05	0.000214	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.37e-05	0.000212	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.37e-05	0.000212	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.25e-05	0.000209	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.22e-05	0.000208	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.13e-05	0.000206	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.11e-05	0.000206	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.11e-05	0.000206	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	8.1e-05	0.000205	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.1e-05	0.000205	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.07e-05	0.000204	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.03e-05	0.000203	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—AGT—dilated cardiomyopathy	7.99e-05	0.000202	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.99e-05	0.000202	CbGpPWpGaD
Amoxapine—SLC6A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.97e-05	0.000202	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.96e-05	0.000202	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.94e-05	0.000201	CbGpPWpGaD
Amoxapine—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.9e-05	0.0002	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.9e-05	0.0002	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.89e-05	0.0002	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.86e-05	0.000199	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.78e-05	0.000197	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.68e-05	0.000194	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.67e-05	0.000194	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.63e-05	0.000193	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.6e-05	0.000193	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.6e-05	0.000193	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.57e-05	0.000192	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.57e-05	0.000192	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.55e-05	0.000191	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.53e-05	0.000191	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.52e-05	0.000191	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.49e-05	0.00019	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.49e-05	0.00019	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.4e-05	0.000187	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.38e-05	0.000187	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.38e-05	0.000187	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.36e-05	0.000186	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.29e-05	0.000185	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.28e-05	0.000185	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.25e-05	0.000184	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.25e-05	0.000184	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.21e-05	0.000183	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.17e-05	0.000182	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.07e-05	0.000179	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.05e-05	0.000179	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.03e-05	0.000178	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.97e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.94e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	6.93e-05	0.000176	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.92e-05	0.000175	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.9e-05	0.000175	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.85e-05	0.000173	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.84e-05	0.000173	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.81e-05	0.000173	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.8e-05	0.000172	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.79e-05	0.000172	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.74e-05	0.000171	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.73e-05	0.000171	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.71e-05	0.00017	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.68e-05	0.000169	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.68e-05	0.000169	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.63e-05	0.000168	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	6.62e-05	0.000168	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.61e-05	0.000168	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.59e-05	0.000167	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.57e-05	0.000166	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.57e-05	0.000166	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.56e-05	0.000166	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.56e-05	0.000166	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.53e-05	0.000166	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.53e-05	0.000166	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.53e-05	0.000165	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.52e-05	0.000165	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.49e-05	0.000164	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—RAF1—dilated cardiomyopathy	6.49e-05	0.000164	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.45e-05	0.000163	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.44e-05	0.000163	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.43e-05	0.000163	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.43e-05	0.000163	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.43e-05	0.000163	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.4e-05	0.000162	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.37e-05	0.000161	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.35e-05	0.000161	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.31e-05	0.00016	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.3e-05	0.00016	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.29e-05	0.000159	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.26e-05	0.000159	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.26e-05	0.000159	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.24e-05	0.000158	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.21e-05	0.000157	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.17e-05	0.000156	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.16e-05	0.000156	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	6.12e-05	0.000155	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.11e-05	0.000155	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.09e-05	0.000154	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.08e-05	0.000154	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.03e-05	0.000153	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.02e-05	0.000152	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.01e-05	0.000152	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.01e-05	0.000152	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	5.99e-05	0.000152	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.98e-05	0.000152	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.98e-05	0.000151	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.98e-05	0.000151	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.96e-05	0.000151	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.92e-05	0.00015	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.9e-05	0.00015	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	5.89e-05	0.000149	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.88e-05	0.000149	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.88e-05	0.000149	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.85e-05	0.000148	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	5.82e-05	0.000147	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.82e-05	0.000147	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	5.81e-05	0.000147	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.79e-05	0.000147	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.73e-05	0.000145	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	5.65e-05	0.000143	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.62e-05	0.000142	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	5.56e-05	0.000141	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	5.56e-05	0.000141	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.56e-05	0.000141	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	5.55e-05	0.000141	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.55e-05	0.000141	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.55e-05	0.000141	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.54e-05	0.00014	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.52e-05	0.00014	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	5.48e-05	0.000139	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.47e-05	0.000139	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	5.4e-05	0.000137	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.38e-05	0.000136	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	5.32e-05	0.000135	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	5.31e-05	0.000135	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.13e-05	0.00013	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	5.07e-05	0.000129	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.05e-05	0.000128	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.04e-05	0.000128	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.02e-05	0.000127	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.01e-05	0.000127	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.95e-05	0.000125	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	4.94e-05	0.000125	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.87e-05	0.000123	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.83e-05	0.000122	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.81e-05	0.000122	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.79e-05	0.000121	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	4.79e-05	0.000121	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.78e-05	0.000121	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.77e-05	0.000121	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.77e-05	0.000121	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.74e-05	0.00012	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	4.72e-05	0.00012	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.69e-05	0.000119	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.6e-05	0.000116	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.48e-05	0.000113	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.47e-05	0.000113	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—EGFR—dilated cardiomyopathy	4.45e-05	0.000113	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	4.41e-05	0.000112	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.36e-05	0.00011	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.35e-05	0.00011	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.31e-05	0.000109	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	4.3e-05	0.000109	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	4.28e-05	0.000109	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.28e-05	0.000108	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.24e-05	0.000108	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.19e-05	0.000106	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.18e-05	0.000106	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.17e-05	0.000106	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.15e-05	0.000105	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.12e-05	0.000104	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	4.12e-05	0.000104	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.11e-05	0.000104	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.1e-05	0.000104	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	4.09e-05	0.000104	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.09e-05	0.000104	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.09e-05	0.000104	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.03e-05	0.000102	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	3.87e-05	9.8e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	3.86e-05	9.77e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.86e-05	9.77e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	3.85e-05	9.76e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.8e-05	9.64e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.8e-05	9.63e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	3.78e-05	9.58e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.75e-05	9.5e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.75e-05	9.49e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.72e-05	9.43e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.71e-05	9.41e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.7e-05	9.38e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	3.69e-05	9.35e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.64e-05	9.23e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	3.61e-05	9.15e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.56e-05	9.01e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	3.55e-05	8.99e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	3.54e-05	8.96e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.52e-05	8.92e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	3.48e-05	8.82e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.39e-05	8.58e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.32e-05	8.41e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.32e-05	8.4e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.3e-05	8.36e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	3.28e-05	8.3e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.23e-05	8.19e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.91e-05	7.37e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.87e-05	7.28e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.86e-05	7.26e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.86e-05	7.24e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.86e-05	7.24e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.85e-05	7.22e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	2.84e-05	7.2e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.8e-05	7.1e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.8e-05	7.09e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	2.65e-05	6.7e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	2.64e-05	6.7e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.61e-05	6.6e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.57e-05	6.51e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	2.53e-05	6.41e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.52e-05	6.39e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.51e-05	6.35e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.47e-05	6.25e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.46e-05	6.24e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.45e-05	6.22e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.42e-05	6.12e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.42e-05	6.12e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.28e-05	5.77e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	2.25e-05	5.69e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.24e-05	5.69e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.96e-05	4.96e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.95e-05	4.94e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.72e-05	4.36e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.69e-05	4.29e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.69e-05	4.28e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.68e-05	4.26e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.66e-05	4.2e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.54e-05	3.9e-05	CbGpPWpGaD
